Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1997 Oct;123(10):533–538. doi: 10.1007/s004320050101

Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines

Eiji Shimizu 1, MeiRong Zhao 1, Akinori Shinohara 1, Osamu Namikawa 1, Takeshi Ogura 1, Noriyuki Masuda 2, Minoru Takada 2, Masahiro Fukuoka 2, Saburo Sone 1
PMCID: PMC12201746  PMID: 9393586

Abstract

Cell-cycle-dependent phosphorylation of the tumor-suppressor protein product of the retinoblastoma gene (RB) is mediated by a family of cyclin-dependent kinases and cyclins. We examined the expressions of RB protein and cyclin A protein in 13 small-cell lung cancer (SCLC) lines and 14 non-small-cell lung cancer (NSCLC) lines by immunoblotting. RB protein was not present or was of a mutant type in 77% of the SCLC lines (10/13) but was present in all the NSCLC lines. Cyclin A was expressed in 38% of the SCLC lines (5/13) and in 86% of the NSCLC lines (12/14). A positive correlation (P = 0.0034) between expression of cyclin A and wild-type RB protein was found by Fisher's exact probability test. Densitometric analysis of the expression of RB protein in RB(+) lung cancer lines showed that the phosphorylated form was predominant in 2/3 of the SCLC and 8/14 of the NSCLC lines. The positive correlation between the expressions of RB protein and cyclin A suggests that RB protein in most RB(+) lung cancer cell lines is a target of cyclin-A-dependent kinase and that the tumor-suppressor function may be inactivated by phosphorylation.

Keywords: Key words Lung cancer, NSCLC, SCLC, Cyclin A, Retinoblastoma gene, RB, Immunoblotting

Footnotes

Received: 10 October 1996 / Accepted: 9 June 1997


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES